Drew Weissman Debunks RFK Jr. Advisor’s COVID Shot Claims

Okay, here’s a breakdown of the key points from the provided text, focusing on the expert’s (unnamed, but clearly⁣ a leading researcher in mRNA technology) responses to concerns about mRNA vaccine biodistribution and persistence:

Core Argument: mRNA does not widely distribute or persist in the body.

*⁣ Spike Protein Detection Issues: The expert dismisses claims of widespread spike protein ⁣detection as stemming from flawed ⁤assays. Specifically, they criticize the ultra-sensitive assay used in a preprint by Akiko Iwasaki and her⁢ Yale team, stating it produces⁢ a⁢ lot of “noise” and unreliable results. they emphasize that findings below a certain threshold shouldn’t be considered real. They also note that other, more reliable assays don’t find circulating spike protein. Iwasaki herself acknowledged the need for more sensitive and accurate methods⁢ to validate her findings.
* Extensive Research: The expert states they and others have ⁣conducted extensive research (mice, macaques, rabbits, and humans at⁤ vaccine doses) and have not found mRNA circulating in key organs like the placenta, ⁢testes, heart, eye, or brain – locations frequently cited in concerns.
* mRNA⁢ Degradation Rate: The expert emphatically states that mRNA degrades very rapidly, even with modifications to increase stability. They state it lasts a maximum of 24 hours, and the idea of it persisting for six months is “absolutely impossible.”
* Assay Manipulation: The expert suggests that it’s possible to design an assay to produce any desired result, implying that some researchers are manipulating their methods to support pre-conceived conclusions.

Response to Specific Concerns (Dr. Retsef Levi):

* The expert directly refutes Dr. Levi’s concerns about “wide biodistribution and prolonged persistence of spike, mRNA and nano-lipid particles,” and prolonged immune responses.The core of their argument is that the biodistribution and persistence simply don’t happen.

in essence, the expert is strongly defending ⁤the safety profile of mRNA vaccines, arguing that fears about widespread distribution and long-term persistence of the mRNA are ⁤unfounded and based on flawed data or misinterpretations.

Important note: This is a⁢ one-sided viewpoint from a leading researcher. While the expert presents a strong case, it’s important to remember that scientific debate is ongoing, and other researchers may have different interpretations of the data.